EUVIMEDEUVIMED entdecken
Crossref

The genomic landscape of cutaneous squamous cell carcinoma in Japan

Junji Kato iD, Tokimasa Hida iD, Masashi Idogawa iD, Takashi Tokino, Hisashi Uhara iD

The Journal of Dermatology · 2025

DOI: 10.1111/1346-8138.17592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Dermatology, 2025. Verfasst von Junji Kato und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: Skin Neoplasms, Carcinoma, Squamous Cell, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Comprehensive studies of the genetic profiles of cutaneous squamous cell carcinoma (cSCC) in Japanese patients have been lacking, although an understanding of these profiles is crucial for improving treatment outcomes. Since 2019, comprehensive genomic profiling (CGP) has been covered by Japan's health insurance, and the resulting data have been compiled into a comprehensive database by the country's Center for Cancer Genomics and Advanced Therapeutics (C‐CAT). In this retrospective study, we used CGP data from the C‐CAT database to analyze genomic characteristics of cSCC in Japanese patients. The patients' clinical and genomic data, including the chemotherapy regimens, tumor mutational burden (TMB), and survival status, were obtained. We analyzed the cases of 152 patients, with only those evaluated by the FoundationOne® CDx included for accuracy. Among the 152 patients, the most common gene oncogenic alterations were observed in TP53 (67%), CDKN2A (54%), TERT (49%), CDKN2B (33%), and NOTCH1 (18%). TMB‐high (≥10 mut/Mb) was observed in 27% ( n = 41) of the patients, with a median age of 75 years for this group. TMB‐low (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsCarcinoma, Squamous CellBiomarkers, TumorHumansAgedJapanMaleFemaleRetrospective StudiesMiddle AgedAged, 80 and overMutationReceptor, Notch1AdultTelomeraseGenomicsTumor Suppressor Protein p53Cyclin-Dependent Kinase Inhibitor p15Cyclin-Dependent Kinase Inhibitor p16

Stichwörter der Autor:innen

C‐CATcomprehensive genomic profilingcutaneous squamous cell carcinomatumor mutational burden

Substanzen

Receptor, Notch1NOTCH1 protein, humanBiomarkers, TumorTP53 protein, humanTelomeraseTERT protein, humanTumor Suppressor Protein p53CDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p15Cyclin-Dependent Kinase Inhibitor p16

Autor:innen und Institutionen

  • Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Department of Medical Genome Sciences, Cancer Research Institute, Sapporo Medical University School of Medicine, Sapporo, Japan.

ORCID-Profile: Junji Kato, Tokimasa Hida, Masashi Idogawa, Hisashi Uhara

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Kato, J., Hida, T., Idogawa, M., Tokino, T., & Uhara, H. (2025). The genomic landscape of cutaneous squamous cell carcinoma in Japan. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17592

Vancouver

Kato J, Hida T, Idogawa M, Tokino T, Uhara H. The genomic landscape of cutaneous squamous cell carcinoma in Japan. The Journal of Dermatology. 2025. doi:10.1111/1346-8138.17592

BibTeX
@article{Kato2025,
  author = {Kato, Junji and Hida, Tokimasa and Idogawa, Masashi and Tokino, Takashi and Uhara, Hisashi},
  title = {The genomic landscape of cutaneous squamous cell carcinoma in Japan},
  journal = {The Journal of Dermatology},
  year = {2025},
  doi = {10.1111/1346-8138.17592}
}
Kostenlos starten →